Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wohn

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Frontiers in Pharmacology|December 21, 2020
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma CellsTzu-En Huang, Yi-Ning Deng, Jui-Ling Hsu, et al.
The Prostate|August 16, 2023
Mechanistic study of dual-function inhibitors targeting topoisomerase II and Rad51-mediated DNA repair pathway against castration-resistant prostate cancerYi-Chang Chiang, Wohn-Jenn Leu, Yi-Chin Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 6, 2024
Decoding Upconversion-Emitting Phase in Complex Composites Through Single-Particle-Level Upconversion Imaging and Density Functional Theory CalculationsYuwaraj K Kshetri, Bina Chaudhary, Jongwoo Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in miceChristian Wohn, Julia L Ober-Blöbaum, Stefan Haak, et al.
Oncotarget|December 13, 2017
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathwaysMei-Ling Chan, Chia-Chun Yu, Jui-Ling Hsu, et al.
The Journal of Investigative Dermatology|October 28, 2018
Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of PsoriasisRebecca Schüler, Anna Brand, Sabrina Klebow, et al.
Annals of Hematology|July 5, 2024
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)Susanne Isfort, Nikolas von Bubnoff, Haifa Kathrin Al-Ali, et al.
Oncotarget|October 22, 2016
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathwaysWohn-Jenn Leu, Sharada Prasanna Swain, She-Hung Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2011
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expressionAndrew Johnston, Xianying Xing, Andrew M Guzman, et al.
International Journal of Environmental Research and Public Health|November 27, 2021
Indoor Air Quality Prior to and Following School Building Renovation in a Mid-Atlantic School DistrictSandra E Zaeh, Kirsten Koehler, Michelle N Eakin, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Frontiers in Pharmacology|December 21, 2020
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma CellsTzu-En Huang, Yi-Ning Deng, Jui-Ling Hsu, et al.
The Prostate|August 16, 2023
Mechanistic study of dual-function inhibitors targeting topoisomerase II and Rad51-mediated DNA repair pathway against castration-resistant prostate cancerYi-Chang Chiang, Wohn-Jenn Leu, Yi-Chin Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 6, 2024
Decoding Upconversion-Emitting Phase in Complex Composites Through Single-Particle-Level Upconversion Imaging and Density Functional Theory CalculationsYuwaraj K Kshetri, Bina Chaudhary, Jongwoo Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2013
Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in miceChristian Wohn, Julia L Ober-Blöbaum, Stefan Haak, et al.
Oncotarget|December 13, 2017
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathwaysMei-Ling Chan, Chia-Chun Yu, Jui-Ling Hsu, et al.
The Journal of Investigative Dermatology|October 28, 2018
Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of PsoriasisRebecca Schüler, Anna Brand, Sabrina Klebow, et al.
Annals of Hematology|July 5, 2024
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)Susanne Isfort, Nikolas von Bubnoff, Haifa Kathrin Al-Ali, et al.
Oncotarget|October 22, 2016
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathwaysWohn-Jenn Leu, Sharada Prasanna Swain, She-Hung Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 19, 2011
IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expressionAndrew Johnston, Xianying Xing, Andrew M Guzman, et al.
International Journal of Environmental Research and Public Health|November 27, 2021
Indoor Air Quality Prior to and Following School Building Renovation in a Mid-Atlantic School DistrictSandra E Zaeh, Kirsten Koehler, Michelle N Eakin, et al.
Pageof 19